Journal for ImmunoTherapy of Cancer

Biochemistry · Cancer Research · Immunology and Microbiology

Impact Factor
8.881
2022
H-Index
117.000
2023
SJR
3.728
2023

I. Journal Information

ISSN20511426
CountryUnited Kingdom
PublisherBMJ Publishing Group
Subject AreasBiochemistry · Cancer Research · Immunology and Microbiology
Publication TypeJournals
Active Years2013-2020
CompetitivenessNo clear consensus
Publication TimeNo clear consensus
WebsiteVisit journal
JIF 2022–202310.300
2019-2020 SCR Rank317
2020-2021 SCR Rank256

II. Scope & Description

The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.

III. Impact Factor History

Year2-Year IF3-Year IF4-Year IF
20228.88110.23210.936
202110.67712.01412.330
202011.36711.63611.259
20199.0938.9738.258
20187.7587.2837.235
20175.7986.1126.042
20165.1125.2125.212
20154.9685.0165.016
20142.238——

Note: impact factor data for reference only.

IV. SCImago Journal Rank (SJR)

SJR measures scientific influence, weighting citations by the prestige of the citing journal.

YearSJR Score
20233.728
20223.403
20213.450
20205.060
20194.194
20183.337
20172.798
20162.668
20151.929

V. H-Index

The H-Index measures both the productivity and citation impact of a journal's publications.

YearH-Index
2023117.000
2022100.000
202180.000
202061.000

How to Get Published

https://jitc.bmj.com/pages/authors/#submission_guidelines